Maintenance Gabapentin to Prolong Pregnancy.
- Registration Number
- NCT02056899
- Lead Sponsor
- State University of New York at Buffalo
- Brief Summary
This is a pilot study to evaluate the tolerability and effects of maintenance gabapentin therapy on the rate of premature birth in women who have had preterm labor.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 4
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Gabapentin Gabapentin -
- Primary Outcome Measures
Name Time Method Rate of premature birth (before 37 weeks gestation) At delivery
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie gabapentin's effect on preterm labor and premature birth?
How does maintenance gabapentin compare to standard tocolytic agents in delaying preterm birth?
Are there specific biomarkers that predict response to gabapentin in preterm labor management?
What adverse events are associated with prolonged gabapentin use during pregnancy and how are they managed?
What combination therapies or alternative drugs show promise in preterm labor treatment alongside gabapentin?
Trial Locations
- Locations (1)
University at Buffalo
🇺🇸Buffalo, New York, United States
University at Buffalo🇺🇸Buffalo, New York, United States